For Further Study:
Can Magic Mushrooms Unlock Depression? | Rosalind Watts | TEDxOxford
The science of psilocybin and its use to relieve suffering
"Leading psychopharmacologist Roland Griffiths discloses the ways that psychedelic drugs can be used to create spiritually meaningful, personally transformative experiences for all patients, especially the terminally ill."
From the article "Could a Club Drug Be the Secret to Curing PTSD?" that has just appeared in the March issue of Elle magazine:
"Before Ecstasy became famous in the 1990s as the street drug of choice among ravers and curious college kids, a loosely knit network of psychiatrists and psychologists experimented with giving patients medical-grade MDMA, a synthetic compound originally developed by a Merck chemist in the early 1900s, to treat anxiety and depression."
"So far, 77 percent of the participants who have received MDMA in the Boulder pilot no longer meet the diagnostic criteria for PTSD, according to Marcela Ot'alora, the study's lead investigator. After another clinical trial in Charleston, South Carolina, a similar effect was seen in 83 percent of the group that received MDMA treatment (compared to just 25 percent of the group who received talk therapy alone). Perhaps most encouragingly, three and a half years after the Charleston study was completed, the benefits largely held: Three-quarters of the MDMA-treated patients who'd been deemed clinically free of PTSD remained free of it,"